Banner

Biologics Market - By Type (Monoclonal Antibodies, Therapeutic Proteins, Vaccines), By Route Of Administration (Oral, Others (IV Or IP)), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription Drugs, OTC Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), And By Region, Opportunities And Strategies – Global Forecast To 2023

Starting Price : $6000.00 $4020.00 | Pages : 391 | Published : December 2020 | SKU CODE : o&s188 | Format :

Request Sample

Biologics Market Definition

The biologics market consists of sales of biologics and related services by entities (organizations, sole traders and partnerships) that produce biologics or biosimilars to treat and prevent various microbial diseases and cancers. The biologics market comprises companies manufacturing biological products that are derived from genetically modified proteins and human genes. Biologics products include a wide range of recombinant therapeutic proteins, gene therapy tissues, somatic cells, vaccines, and allergenics.

Biologics products are subjected to various laws and regulations that deal with patenting, testing, safety, efficacy and marketing. Biologics products are isolated from natural sources such as human, animal, and microorganisms by biotechnological methods and other cutting-edge technologies.  Biosimilars should have similar safety and efficacy compared to the reference biologic product. The biologics market comprises of biologics and biosimilar drugs through oral, IV and other delivery routes for the treatment of chronic diseases.

Biologics Market Size

The global biologics market reached a value of nearly $269,152.8 million in 2019, having increased at a compound annual growth rate (CAGR) of 12.6% since 2015. The market is expected to decline from $269,152.8 million in 2019 to $239,168.6 million in 2020 at a rate of -11.1%. The decline is mainly due to lockdown and social distancing norms imposed by various countries and economic slowdown across countries owing to the COVID-19 outbreak and the measures to contain it. The market is then expected to recover and grow at a CAGR of 14.7% from 2021 and reach $464,604.9 million in 2023.

Growth in the historic period resulted from aging population, government initiatives, ability to command high prices, and increased need for immunology. Factors that negatively affected growth in the historic period were pricing pressures from regulators, and lack of awareness on biosimilars among primary care physicians and specialists.

Going forward, increase in funding, technological advances, increase in healthcare access, robust research and development activities for development of oral biologics, and lean towards pills over injections will drive the growth. Factors that could hinder the growth of the biologics market in the future include high stringency and low turnover for clinical trials, stringent regulations related to biosimilar approvals, prolonged production and approval time, and nomenclature challenges.

Biologics Market Drivers

The key drivers of the biologics market include:

Technological Advances

Technology is expected to be a continued driver of market growth during this period. An area of particular development is likely to be physiology simulation modeling. Markets such as this one will benefit from the greater efficiencies offered by developments in this area. For example, Eli Lilly and Pfizer have adopted Amazon’s Elastic Compute Cloud (EC2) platform to conduct simulation models in early drug discovery that have been operational within hours, whereas traditional models would have taken weeks to conduct simulations. The Open Innovation Drug Discovery program is another initiative by Lilly to enhance the research and development of biologics.

Biologics Market Restraints

The key restraints on the biologics market include:

Stringent Regulations Related To Biosimilar Approvals

Stringent regulations imposed on approvals of biosimilars is anticipated to hinder the growth of the biologics market in the forecast period. The governments of different regions impose different rules regarding the production and use of biologics and biosimilars. Further, issues such as patent infringement or agreement issues restrict the manufacturers of biologics and biosimilars from commercializing the government-approved biosimilars. The US Food and Drug Administration requires a double regulatory approval for biosimilars, restricting the use of biosimilars as an interchangeable drug to biologics, whereas, in Europe, the European Medicines Agency (EMA) approves biosimilars as interchangeable products for biologics. In February 2019, out of the total 17 approved biosimilars, only 7 biosimilars including 4 originating biologics could enter the US commercial market. The robust government policies for approval of these drugs negatively impact manufacturers in the biologics market.

Biologics Market Trends

Major trends influencing the biologics market include:

Robust Research & Development

The biologics market is witnessing robust research and development activities. These research and development activities have led to increasing success rates in clinical trials for biologics. Research and development is being carried out by market leaders in the biologics market as they continuously strive to make breakthroughs in the market in the form of new and effective biologics. For instance, Biocon Limited is developing tregopil, an oral prandial insulin to treat patients with type 2 diabetes, which is in phase II/III clinical trials. Currently, insulin tregopil is in Phase II/III clinical study for Type 2 diabetes patients. In 2019, Jerusalem based Oramed Pharmaceuticals developed an oral insulin drug, which is in phase-2 trials, named ORMD-0801 to treat type-2 diabetes.  In September 2019, Novo Nordisk, a Danish multinational pharmaceutical company, received approval from the US Food and Drug Administration to introduce its Rybelsus oral drug for diabetes. Rybelsus drug is an oral form of semaglutide and used to treat patients with type 2 diabetes.

Demand For Biologics In The Treatment Of Complex Diseases

Biologics are being widely used to provide effective treatment for many complex diseases such as rheumatoid arthritis, psoriasis, and Crohn’s disease that have limited treatment options. There has been a significant improvement in the treatment of rheumatoid arthritis patients who do not respond to traditional disease-modifying anti-rheumatic drugs. The key biologics used for the treatment of rheumatoid arthritis include Abatacept (Orencia), Adalimumab (Humira), Anakinra (Kineret), Infliximab (Remicade), and Rituximab (Rituxan). Key biologics used to treat psoriasis include Adalimumab (Humira), Etanercept (Enbrel), Infliximab (Remicade), Secukinumab ( Cosentyx). Cimzia (certolizumab pegol), Humira (adalimumab), and Remicade (infliximab), Tysabri (natalizumab) are biologics that are used to treat Crohn’s disease.

Opportunities And Recommendations In The Biologics Market

Opportunities – The top opportunities in the biologics market segmented by type will arise in the monoclonal antibodies segment, which will gain $83,966.0 million of global annual sales by 2023. The top opportunities in the biologics market segmented by distribution channel will arise in the hospital pharmacies segment, which will gain $95,544.3 million of global annual sales by 2023. The top opportunities in the biologics market segmented by route of administration will arise in the others segment, which will gain $192,740.4 million of global annual sales by 2023. The top opportunities in the biologics market segmented by drug classification will arise in the branded drugs segment, which will gain $153,717.8 million of global annual sales by 2023. The top opportunities in the biologics market segmented by mode of purchase will arise in the prescription drugs segment, which will gain $152,134.2 million of global annual sales by 2023.The biologics market size will gain the most in the USA at $88,049.4 million.

Recommendations- To take advantage of the opportunities, the business research company recommends the biologics companies to focus on research & development, use of large molecules, focus on drug development for complex diseases, expand in emerging markets, set up authorized distributors and sales representatives, leverage online pharmacies, targeting local pharmacies to spread awareness, provide competitively priced offerings in low-income countries to reach new users, skimmed pricing for innovative drugs, direct-to-customer (DTC) advertising, participate in trade shows and events, increased requirement of R&D scientists.

Biologics Market Segmentation

The biologics market is segmented by type, by distribution channel, by route of administration, by drug classification, by mode of purchase and by geography.?
By Type- The biologics market is segmented by type into
    • a. Monoclonal Antibodies
    • b. Therapeutic Proteins
c. Vaccines The monoclonal antibodies market was the largest segment of the biologics market segmented by type, accounting for 42.6% of the total in 2019. Going forward, the therapeutic proteins segment is expected to be the fastest growing segment in the biologics market segmented by type, at a CAGR of 14.9% during 2019-2023.
Sub-Segmentation –
By Type – The monoclonal antibodies (MAbS) market is further segmented by type into
    • a. Anti-Cancer MAbS
    • b. Immunological MAbS
    • c. Anti-Infective Monoclonal Antibodies (MAbs)
    • d. Cardiovascular And Cerebrovascular MAbS
    • e. Neuropharmacological MABS
    • f. Others - Monoclonal Antibodies (MAbs)
The anti-cancer MAbS market was the largest segment of the monoclonal antibodies market segmented by type, accounting for 50.5% of the total in 2019. It is also expected to be the fastest growing segment in the monoclonal antibodies market segmented by type, at a CAGR of 15.3% during 2019-2023. The therapeutic proteins market is further segmented by type into
    • a. Metabolic Disorders Therapeutic Proteins
    • b. Cancer Therapeutic Proteins
    • c. Cardiovascular Therapeutic Proteins
    • d. Immunological Therapeutic Proteins
    • e. Others - Therapeutic Proteins
The metabolic disorders therapeutic proteins market was the largest segment of the therapeutic proteins market segmented by type, accounting for 35.4% of the total in 2019. It is also expected to be the fastest growing segment in the therapeutic proteins market segmented by type, at a CAGR of 15.5% during 2019-2023. The vaccines market is further segmented by type into
    • a. Anti-Infective Vaccines
    • b. Autoimmunity Vaccines
    • c. Others-Vaccines
The anti-infective vaccines market was the largest segment of the vaccines market segmented by type, accounting for 43.6% of the total in 2019. It is also expected to be the fastest growing segment in the vaccines market segmented by type, at a CAGR of 14.4% during 2019-2023.
By Route Of Administration - The biologics market is segmented by route of administration into
    • a. Oral
    • b. Others (IV or IP)
The network function virtualization (NFV) was the largest segment of the biologics market segmented by type of network technology, accounting for 52.2% of the total in 2019. Going forward, the fog computing is expected to be the fastest growing segment in the biologics market, at a CAGR of 94.9% during 2019-2023.
By Drug Classification - The biologics market is segmented by drug classification into
    • a. Branded Drugs
    • b. Generic Drugs
The branded drugs market was the largest segment of the biologics market segmented by drug classification, accounting for 80.2% of the total in 2019. Going forward, the generic drugs segment is expected to be the fastest growing segment in the biologics market segmented by drug classification, at a CAGR of 15.5% during 2019-2023.
By Mode Of Purchase - The biologics market is segmented by drug classification into
    • a. Prescription Drugs
    • b. OTC Drugs
The prescription drugs market was the largest segment of the biologics market segmented by mode of purchase, accounting for 78.1% of the total in 2019. Going forward, the OTC drugs segment is expected to be the fastest growing segment in the biologics market segmented by mode of purchase, at a CAGR of 14.8% during 2019-2023.
By Distribution Channel - The biologics market is segmented by distribution channel into
    • a. Hospital Pharmacies
    • b. Retail Pharmacies
    • c. Online Pharmacies
The hospital pharmacies market was the largest segment of the biologics market segmented by distribution channel, accounting for 50.3% of the total in 2019. Going forward, the online pharmacies segment is expected to be the fastest growing segment in the biologics market segmented by distribution channel, at a CAGR of 21.1% during 2019-2023.
Segmentation By Geography- The biologics market is segmented into
    • o North America
      • USA
      • Canada
      • Mexico
    • o Western Europe
      • UK
      • Germany
      • France
      • Italy
      • Spain
      • Austria
      • Belgium
      • Denmark
      • Finland
      • Ireland
      • Netherlands
      • Norway
      • Portugal
      • Sweden
      • Switzerland
    • o Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • Indonesia
      • South Korea
      • Hong Kong
      • Malaysia
      • New Zealand
      • Philippines
      • Singapore
      • Thailand
      • Vietnam
    • o Eastern Europe
      • Russia
      • Czech Republic
      • Poland
      • Romania
    • o South America
      • Brazil
      • Argentina
      • Chile
      • Colombia
      • Peru
      • Venezuela
    • o Middle East
      • Israel
      • Saudi Arabia
      • Turkey
      • UAE
    • o Africa
      • Egypt
      • Nigeria
      • South Africa
Asia Pacific was the largest region in the global biologics market, accounting for 53.1% of the total in 2019. It was followed by Asia Pacific, Western Europe, and then the other regions. Going forward, the fastest-growing regions in the biologics market will be Asia Pacific, and Africa.

Biologics Competitive Landscape

Major Competitors are:
    • • Pfizer Inc.
    • • F. Hoffmann-La Roche AG
    • • AbbVie Inc.
    • • Merck & Co., Inc.
    • • Johnson & Johnson
Other Competitors Include:
    • • Bristol Myers Squibb Company
    • • GlaxoSmithKline Plc.
    • • Amgen Inc.
    • • Sanofi S.A.
    • • Eli Lilly and Company
    • • Wockhardt
    • • Zydus Cadilla
    • • Asahi Glass Co. Ltd
    • • China Biologic Products Holdings Inc
    • • China Regenerative Medicine International
    • • ABLbio
    • • Adimmune
    • • Henlius
    • • Innovent Biologics
    • • Bio-Thera
    • • Hisun Pharma
    • • 3SBio
    • • Beijing ShuangLu Pharmaceuticals
    • • Qilu Pharmaceutical
    • • Shanghai Fosun Pharmaceuticals
    • • Biocon
    • • Dr.Reddy’s
    • • Mylan
    • • Kyowa Hakko Kirin
    • • Takeda
    • • Mitsubishi Tanabe
    • • AGC Biologics
    • • Tonghua Dongbao Pharmaceutical Co
    • • Biogen Idec
    • • Novartis AG
    • • BiosanaPharma
    • • Teva UK Limited
    • • AstraZeneca
    • • Abbott Laboratories
    • • Vectura Group
    • • Roche
    • • Lonza
    • • Seqens
    • • Piramal Pharma Solutions
    • • Corden Pharma
    • • Procos SpA
    • • BSP Pharmaceuticals
    • • Microgen
    • • Geropharm
    • • Valenta
    • • NovaMedica
    • • SynBio
    • • Rani Therapeutics
    • • Emisphere Technologies, Inc.
    • • Enteris BioPharma
    • • Allena Pharmaceuticals
    • • Biogen Inc.
    • • Apotex
    • • Gilead Sciences
    • • Hypermarcas
    • • Aché
    • • Eurofarma
    • • Teuto Brasileiro
    • • BioMarin Pharmaceutical
    • • BIONOVIS BRASIL
    • • Ecopharm
    • • Julphar
    • • SPIMACO ADDWAEIH
    • • Hikma Pharmaceuticals
    • • BBI Solutions
    • • Aspen Pharmacare
    • • Amoun Pharmaceuticals CO Ltd
    • • 54gene
    • • Baxter International
    • • Altis Biologics

    Table Of Contents

    1. Biologics Market Executive Summary

    2. Table of Contents

    3. List of Figures

    4. List of Tables

    5. Report Structure

    6. Introduction

    6.1. Segmentation By Geography

    6.2. Biologics Market Segmentation By Type

    6.2.1. Monoclonal Antibodies (MAbS) Segmentation By Type

    6.2.2. Therapeutic Proteins Segmentation By Type

    6.2.3. Vaccines Segmentation By Type

    6.3. Biologics Market Segmentation By Route Of Administration

    6.4. Biologics Market Segmentation By Mode Of Purchase

    6.5. Biologics Market Segmentation By Distribution Channel

    7. Biologics Market Characteristics

    7.1. Market Definition

    7.2. Segmentation By Type

    7.2.1. Therapeutic Proteins

    7.2.2. Monoclonal Antibodies ((MAbS)

    7.2.3. Vaccines

    7.3. Market Segmentation By Route Of Administration

    7.3.1. Oral

    7.3.2. Others (IV and IP)

    7.4. Market Segmentation By Drug Classification

    7.4.1. Branded Drugs

    7.4.2. Generic Drugs

    7.5. Market Segmentation By Mode Of Purchase

    7.5.1. Prescription Drugs

    7.5.2. Over-The-Counter (OTC) Drugs

    7.6. Market Segmentation By Distribution Channel

    7.6.1. Hospital Pharmacies

    7.6.2. Retail Pharmacies

    7.6.3. Online Pharmacies

    8. Biologics Market, Supply Chain Analysis

    8.1. Raw Material Suppliers

    8.2. Research and Development

    8.2.1. Clinical Studies

    8.2.2. Contract Research Organization (CRO)

    8.2.3. Approval

    8.3. Biologics Manufacturing

    8.3.1. Contract Manufacturing Organization (CMO)

    8.4. Distribution

    8.4.1. Wholesalers/Distributors

    8.4.2. Retailers

    8.4.3. End Users

    9. Biologics Market Product Analysis – Product Examples

    10. Biologics Market Customer Information

    10.1. Awareness Of The Patients For Biosimilars And Biologics

    10.2. Perception On The Adoption Of Biosimilars

    10.3. Patients’ Preference For Biosimilar Over Biologics

    10.4. Preference For Influenza Vaccines With Fewer Side Effects

    10.5. Hesitance Of Patients Towards Immunization Vaccines Due To Its Side Effects

    11. Biologics Market Trends And Strategies

    11.1. Revised FDA Regulations To Facilitate Biologics Drug Development

    11.2. Higher Profit Margins For Biologics

    11.3. Shift From Small Molecules To Biologics

    11.4. Robust Research & Development

    11.5. Demand For Biologics In The Treatment Of Complex Diseases

    12. Impact Of Covid-19 On Biologics Market

    12.1. Impact On R&D Funding

    12.2. Impact On Supply Chain

    12.3. Recovery

    13. Global Biologics Market Size And Growth

    13.1. Market Size

    13.2. Historic Market Growth, 2015 – 2019, Value ($ Million)

    13.2.1. Drivers Of The Market 2015 – 2019

    13.2.2. Restraints On The Market 2015-19

    13.3. Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    13.3.1. Drivers Of The Market 2019 – 2023

    13.3.2. Restraints On The Market 2019-2023

    14. Biologics Market, Regional Analysis

    14.1. Global Biologics Market, By Region, Historic and Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    14.2. Global Biologics Market, 2015 – 2023, Historic And Forecast, By Region

    14.3. Global Biologics Market, 2019-2023, Growth And Market Share Comparison, By Region

    15. Global Biologics Market Segmentation

    15.1. Global Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    15.1.1. Monoclonal Antibodies

    15.1.2. Therapeutic Proteins

    15.1.3. Vaccines

    15.1.4. Global Monoclonal Antibodies (MAbS) Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    15.1.5. Anti-Cancer MAbS

    15.1.6. Immunological MAbS

    15.1.7. Anti-Infective Monoclonal Antibodies (MAbS)

    15.1.8. Cardiovascular And Cerebrovascular MAbS

    15.1.9. Neuropharmacological MABS

    15.1.10. Others - Monoclonal Antibodies (MAbs)

    15.1.11. Global Therapeutic Proteins Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    15.1.12. Metabolic Disorders Therapeutic Proteins

    15.1.13. Cancer Therapeutic Proteins

    15.1.14. Cardiovascular Therapeutic Proteins

    15.1.15. Immunological Therapeutic Proteins

    15.1.16. Others - Therapeutic Proteins

    15.1.17. Global Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    15.1.18. Anti-Infective Vaccines

    15.1.19. Autoimmunity Vaccines

    15.1.20. Others-Vaccines

    15.2. Global Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    15.2.1. Oral

    15.2.2. Others

    15.3. Global Biologics Market, Segmentation By Drug Classification, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    15.3.1. Branded Drugs

    15.3.2. Generic Drugs

    15.4. Global Biologics Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    15.4.1. Prescription Drugs

    15.4.2. OTC Drugs

    15.5. Global Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    15.5.1. Hospital Pharmacies

    15.5.2. Retail Pharmacies

    15.5.3. Online Pharmacies

    16. Global Biologics Market Comparison with Macro Economic Factors

    16.1. Biologics Market Size, Percentage Of GDP, Global

    16.2. Per Capita Average Biologics Market Expenditure, Global

    17. Asia-Pacific Biologics Market

    17.1. Asia-Pacific Biologics Market Overview

    17.1.1. Region Information

    17.1.2. Market Information

    17.1.3. Impact Of COVID-19

    17.1.4. Background Information

    17.1.5. Government Initiatives

    17.1.6. Regulations

    17.1.7. Regulatory Bodies

    17.1.8. Major Associations

    17.1.9. Taxes Levied

    17.1.10. Corporate Tax Structure

    17.1.11. Investments

    17.1.12. Major Companies

    17.2. Asia-Pacific Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    17.3. Asia-Pacific Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    17.4. Asia-Pacific Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    17.5. Asia-Pacific Biologics Market, 2019, By Country, Value ($ Million)

    17.6. Asia-Pacific Biologics Market, 2015 – 2023, Historic And Forecast, By Country

    17.7. Asia-Pacific Biologics Market, 2019 – 2023, Growth And Market Share Comparison, By Country

    17.8. Asia-Pacific Biologics Market Metrics

    17.8.1. Per Capita Biologics Expenditure, 2019, Asia-Pacific Major Countries

    17.8.2. Estimated Number Of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, Asia-Pacific Countries

    17.8.3. Estimated Number Of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, Asia-Pacific Countries

    17.9. Asia-Pacific Biologics Market: Country Analysis

    17.10. Australia Biologics Market

    17.11. Australia Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    17.12. Australia Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    17.13. Australia Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    17.14. China Biologics Market

    17.15. China Biologics Market Overview

    17.15.1. Country Information

    17.15.2. Market Information

    17.15.3. Impact Of COVID-19

    17.15.4. Background Information

    17.15.5. Government Initiatives

    17.15.6. Regulations

    17.15.7. Regulatory Bodies

    17.15.8. Major Associations

    17.15.9. Taxes Levied

    17.15.10. Corporate Tax Structure

    17.15.11. Investments

    17.15.12. Major Companies

    17.16. China Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    17.17. China Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    17.18. China Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    17.19. Hong Kong Biologics Market

    17.20. Hong Kong Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    17.21. Hong Kong Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    17.22. India Biologics Market

    17.23. India Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    17.24. India Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    17.25. India Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    17.26. Indonesia Biologics Market

    17.27. Indonesia Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    17.28. Indonesia Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    17.29. Indonesia Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    17.30. Japan Biologics Market

    17.31. Japan Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    17.32. Japan Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    17.33. Japan Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    17.34. Malaysia Biologics Market

    17.35. Malaysia Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    17.36. Malaysia Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    17.37. New Zealand Biologics Market

    17.38. New Zealand Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    17.39. New Zealand Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    17.40. Philippines Biologics Market

    17.41. Philippines Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    17.42. Philippines Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    17.43. Singapore Biologics Market

    17.44. Singapore Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    17.45. Singapore Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    17.46. South Korea Biologics Market

    17.47. South Korea Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    17.48. South Korea Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    17.49. South Korea Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    17.50. Thailand Biologics Market

    17.51. Thailand Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    17.52. Thailand Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    17.53. Vietnam Biologics Market

    17.54. Vietnam Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    17.55. Vietnam Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    18. Western Europe Biologics Market

    18.1. Western Europe Biologics Market Overview

    18.1.1. Region Information

    18.1.2. Market Information

    18.1.3. COVID Impact

    18.1.4. Background Information

    18.1.5. Government Initiatives

    18.1.6. Regulations

    18.1.7. Regulatory Bodies

    18.1.8. Major Associations

    18.1.9. Taxes Levied

    18.1.10. Corporate Tax Structure

    18.1.11. Investments

    18.1.12. Major Companies

    18.2. Western Europe Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    18.3. Western Europe Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    18.4. Western Europe Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    18.5. Western Europe Biologics Market, 2019, By Country, Value ($ Million)

    18.6. Western Europe Biologics Market, 2015 – 2023, Historic And Forecast, By Country

    18.7. Western Europe Biologics Market, 2019 – 2023, Growth And Market Share Comparison, By Country

    18.8. Western Europe Biologics Market Metrics

    18.8.1. Per Capita Biologics Expenditure, 2019, Western Europe Major Countries

    18.8.2. Estimated Number Of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, Western Europe Countries

    18.8.3. Estimated Number Of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, Western Europe Countries

    18.9. Western Europe Biologics Market: Country Analysis

    18.10. Austria Biologics Market

    18.11. Austria Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    18.12. Austria Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    18.13. Belgium Biologics Market

    18.14. Belgium Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    18.15. Belgium Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    18.16. Denmark Biologics Market

    18.17. Denmark Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    18.18. Denmark Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    18.19. Finland Biologics Market

    18.20. Finland Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    18.21. Finland Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    18.22. France Biologics Market

    18.23. France Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    18.24. France Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    18.25. France Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    18.26. Germany Biologics Market

    18.27. Germany Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    18.28. Germany Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    18.29. Germany Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    18.30. Ireland Biologics Market

    18.31. Ireland Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    18.32. Ireland Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    18.33. Italy Biologics Market

    18.34. Italy Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    18.35. Italy Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    18.36. Italy Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    18.37. Netherlands Biologics Market

    18.38. Netherlands Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    18.39. Netherlands Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    18.40. Norway Biologics Market

    18.41. Norway Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    18.42. Norway Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    18.43. Portugal Biologics Market

    18.44. Portugal Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    18.45. Portugal Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    18.46. Spain Biologics Market

    18.47. Spain Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    18.48. Spain Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    18.49. Spain Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    18.50. Sweden Biologics Market

    18.51. Sweden Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    18.52. Sweden Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    18.53. Switzerland Biologics Market

    18.54. Switzerland Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    18.55. Switzerland Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    18.56. UK Biologics Market

    18.57. UK Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    18.58. UK Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    18.59. UK Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    19. Eastern Europe Biologics Market

    19.1. Eastern Europe Biologics Market Overview

    19.1.1. Region Information

    19.1.2. Market Information

    19.1.3. Background Information

    19.1.4. Government Initiatives

    19.1.5. Regulations

    19.1.6. Regulatory Bodies

    19.1.7. Major Associations

    19.1.8. Taxes Levied

    19.1.9. Corporate Tax Structure

    19.1.10. Investments

    19.1.11. Major Companies

    19.2. Eastern Europe Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    19.3. Eastern Europe Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    19.4. Eastern Europe Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    19.5. Eastern Europe Biologics Market, 2019, By Country, Value ($ Million)

    19.6. Eastern Europe Biologics Market, 2015 – 2023, Historic And Forecast, By Country

    19.7. Eastern Europe Biologics Market, 2019 – 2023, Growth And Market Share Comparison, By Country

    19.8. Eastern Europe Biologics Market Metrics

    19.8.1. Per Capita Biologics Expenditure, 2019, Eastern Europe Major Countries

    19.8.2. Estimated Number Of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, Eastern Europe Countries

    19.8.3. Estimated Number Of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, Eastern Europe Countries

    19.9. Eastern Europe Biologics Market: Country Analysis

    19.10. Czech Republic Biologics Market

    19.11. Czech Republic Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    19.12. Czech Republic Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    19.13. Poland Biologics Market

    19.14. Poland Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    19.15. Poland Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    19.16. Romania Biologics Market

    19.17. Romania Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    19.18. Romania Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    19.19. Russia Biologics Market

    19.20. Russia Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    19.21. Russia Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    19.22. Russia Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    20. North America Biologics Market

    20.1. North America Biologics Market Overview

    20.1.1. Region Information

    20.1.2. Market Information

    20.1.3. Impact Of COVID-19

    20.1.4. Background Information

    20.1.5. Government Initiatives

    20.1.6. Regulations

    20.1.7. Regulatory Bodies

    20.1.8. Major Associations

    20.1.9. Taxes Levied

    20.1.10. Corporate Tax Structure

    20.1.11. Investment

    20.1.12. Major Companies

    20.2. North America Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    20.3. North America Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    20.4. North America Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    20.5. North America Biologics Market, 2019, By Country, Value ($ Million)

    20.6. North America Biologics Market, 2015 – 2023, Historic And Forecast, By Country

    20.7. North America Biologics Market, 2019 – 2023, Growth And Market Share Comparison, By Country

    20.8. North America Biologics Market Metrics

    20.8.1. Per Capita Biologics Expenditure, 2019, North America Major Countries

    20.8.2. Estimated Number Of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, North America Countries

    20.8.3. Estimated Number Of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, North America Countries

    20.9. North America Biologics Market: Country Analysis

    20.10. Canada Biologics Market

    20.11. Canada Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    20.12. Canada Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    20.13. Mexico Biologics Market

    20.14. Mexico Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    20.15. Mexico Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    20.16. USA Biologics Market

    20.17. USA Biologics Market Overview

    20.17.1. Country Information

    20.17.2. Market Information

    20.17.3. COVID Impact

    20.17.4. Background Information

    20.17.5. Government Initiatives

    20.17.6. Regulations

    20.17.7. Regulatory Bodies

    20.17.8. Major Associations

    20.17.9. Taxes Levied

    20.17.10. Corporate Tax Structure

    20.17.11. Investment

    20.17.12. Major Companies

    20.18. USA Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    20.19. USA Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    20.20. USA Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    21. South America Biologics Market

    21.1. South America Biologics Market Overview

    21.1.1. Region Information

    21.1.2. Market Information

    21.1.3. COVID Impact

    21.1.4. Background Information

    21.1.5. Government Initiatives

    21.1.6. Regulations

    21.1.7. Regulatory Bodies

    21.1.8. Major Associations

    21.1.9. Taxes Levied

    21.1.10. Corporate Tax Structure

    21.1.11. Investments

    21.1.12. Major Companies

    21.2. South America Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    21.3. South America Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    21.4. South America Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    21.5. South America Biologics Market, 2019, By Country, Value ($ Million)

    21.6. South America Biologics Market, 2015 – 2023, Historic And Forecast, By Country

    21.7. South America Biologics Market, 2019 – 2023, Growth And Market Share Comparison, By Country

    21.8. South America Biologics Market Metrics

    21.8.1. Per Capita Biologics Expenditure, 2019, South America Major Countries

    21.8.2. Estimated Number Of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, South America Countries

    21.8.3. Estimated Number Of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, South America Countries

    21.9. South America Biologics Market: Country Analysis

    21.10. Argentina Biologics Market

    21.11. Argentina Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    21.12. Argentina Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    21.13. Brazil Biologics Market

    21.14. Brazil Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    21.15. Brazil Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    21.16. Brazil Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    21.17. Chile Biologics Market

    21.18. Chile Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    21.19. Chile Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    21.20. Colombia Biologics Market

    21.21. Colombia Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    21.22. Colombia Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    21.23. Peru Biologics Market

    21.24. Peru Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    21.25. Peru Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    21.26. Venezuela Biologics Market

    21.27. Venezuela Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    21.28. Venezuela Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    22. Middle East Biologics Market

    22.1. Middle East Biologics Market Overview

    22.1.1. Region Information

    22.1.2. Market Information

    22.1.3. Impact Of COVID-19

    22.1.4. Background Information

    22.1.5. Government Initiatives

    22.1.6. Regulations

    22.1.7. Regulatory Bodies

    22.1.8. Major Associations

    22.1.9. Taxes Levied

    22.1.10. Corporate Tax Structure

    22.1.11. Investments

    22.1.12. Major Companies

    22.2. Middle East Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    22.3. Middle East Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    22.4. Middle East Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    22.5. Middle East Biologics Market, 2019, By Country, Value ($ Million)

    22.6. Middle East Biologics Market, 2015 – 2023, Historic And Forecast, By Country

    22.7. Middle East Biologics Market, 2019 – 2023, Growth And Market Share Comparison, By Country

    22.8. Middle East Biologics Market Metrics

    22.8.1. Per Capita Biologics Expenditure, 2019, Middle East Major Countries

    22.8.2. Estimated Number Of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, Middle East Countries

    22.8.3. Of the featured countries, Turkey had the lowest average revenue per enterprise in the biologics market with $ 1,681,534. As of 2019, there were 276 biologics enterprises in Turkey. Estimated Number Of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, Middle East Countries

    22.9. Middle East Biologics Market: Country Analysis

    22.10. Israel Biologics Market

    22.11. Israel Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    22.12. Israel Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    22.13. Saudi Arabia Biologics Market

    22.14. Saudi Arabia Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    22.15. Saudi Arabia Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    22.16. Turkey Biologics Market

    22.17. Turkey Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    22.18. Turkey Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    22.19. UAE Biologics Market

    22.20. UAE Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    22.21. UAE Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    23. Africa Biologics Market

    23.1. Africa Biologics Market Overview

    23.1.1. Region Information

    23.1.2. Market Information

    23.1.3. Impact Of COVID-19

    23.1.4. Background Information

    23.1.5. Government Initiatives

    23.1.6. Regulations

    23.1.7. Regulatory Bodies

    23.1.8. Major Associations

    23.1.9. Taxes Levied

    23.1.10. Corporate Tax Structure

    23.1.11. Investments

    23.1.12. Major Companies

    23.2. Africa Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    23.3. Africa Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    23.4. Africa Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

    23.5. Africa Biologics Market, 2019, By Country, Value ($ Million)

    23.6. Africa Biologics Market, 2015 – 2023, Historic And Forecast, By Country

    23.7. Africa Biologics Market, 2019 – 2023, Growth And Market Share Comparison, By Country

    23.8. Africa Biologics Market Metrics

    23.8.1. Per Capita Biologics Expenditure, 2019, Africa Major Countries

    23.8.2. Estimated Number Of Enterprises, Biologics Market, Biologics Market/Number of Enterprises, 2019, Africa Countries

    23.8.3. Estimated Number Of Employees, Biologics Market, Biologics Market/Number of Employees, 2019, Africa Countries

    23.9. Africa Biologics Market: Country Analysis

    23.10. Egypt Biologics Market

    23.11. Egypt Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    23.12. Egypt Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    23.13. Nigeria Biologics Market

    23.14. Nigeria Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    23.15. Nigeria Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    23.16. South Africa Biologics Market

    23.17. South Africa Biologics Market, Historic Market Growth, 2015 – 2019, Value ($ Million)

    23.18. South Africa Biologics Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)

    24. Global Biologics Market Competitive Landscape

    24.1. Company Profiles

    24.2. Pfizer Inc.

    24.2.1. Company Overview

    24.2.2. Products And Services

    24.2.3. Business Strategy

    24.2.4. Financial Overview

    24.3. F. Hoffmann-La Roche AG

    24.3.1. Company Overview

    24.3.2. Products And Services

    24.3.3. Business Strategy

    24.3.4. Financial Overview

    24.4. AbbVie Inc.

    24.4.1. Company Overview

    24.4.2. Products And Services

    24.4.3. Business Strategy

    24.4.4. Financial Overview

    24.5. Merck & Co., Inc., Inc.

    24.5.1. Company Overview

    24.5.2. Products And Services

    24.5.3. Business Strategy

    24.5.4. Financial Overview

    24.6. Johnson & Johnson

    24.6.1. Company Overview

    24.6.2. Products And Services

    24.6.3. Business Strategy

    24.6.4. Financial Overview

    25. Key Mergers And Acquisitions In The Biologics Market

    25.1. Abbvie Acquired Allergan

    25.2. WuXi Biologics Acquired Drug Product Manufacturing Plant From Bayer

    25.3. Takeda Pharmaceutical Company Acquired PvP Biologics, Inc.

    25.4. True North Acquired Stake In Biocon Biologics

    25.5. Catalent, Inc. Acquired Bristol Myers Squibb’s Oral Dose Manufacturing Facility

    25.6. Bristol Myers Acquired Celgene

    25.7. Evotec Acquired Just Biotherapeutics

    25.8. AstraZeneca Strikes Stock Deal With Daiichi Sankyo

    25.9. Boehringer Acquires Rights To ICD Therapeutics And Its Biologics-Delivery Platform

    25.10. Catalent, Inc. Acquired Cook Pharmica LLC

    25.11. ADMA Biologics Acquired Biotest’s Therapy Business

    25.12. Eagle Pharmaceuticals Acquired Arsia Therapeutics

    25.13. Takeda Acquired Baxalta’s Manufacturing Facility

    26. Market Background: Pharmaceuticals Market

    26.1. Pharmaceuticals Market Characteristics

    26.1.1. Market Definition

    26.1.2. Segmentation By Type

    26.2. Global Pharmaceuticals Market, Segmentation By Type, 2015 – 2023, Value ($ Billion)

    26.3. Global Pharmaceuticals Market, 2019, By Region, Value ($ Billion)

    26.4. Global Pharmaceuticals Market, 2015 – 2023, Historic And Forecast, By Region

    27. Biologics Market Opportunities And Strategies

    27.1. Global Biologics Market In 2023 – Countries Offering Most New Opportunities

    27.2. Global Biologics Market In 2023 – Segments Offering Most New Opportunities

    27.3. Global Biologics Market In 2023 – Growth Strategies

    27.3.1. Market Trend Based Strategies

    27.3.2. Competitor Strategies

    28. Biologics Market, Conclusions And Recommendations

    28.1. Conclusions

    28.2. Recommendations

    28.2.1. Product

    28.2.2. Place

    28.2.3. Price

    28.2.4. Promotion

    28.2.5. People

    29. Appendix

    29.1. Market Data Sources

    29.2. Research Methodology

    29.3. Currencies

    29.4. Research Inquiries

    29.5. The Business Research Company

    29.6. Copyright and Disclaimer

List Of Tables

    Table 1: Global Biologics Market, Product Analysis – Product Examples
  • Table 2: Global Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 3: Global Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 4: Global Biologics Market, By Region, Historic and Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 5: Global Biologics Market, By Region, Historic and Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 6: Global Biologics Market, 2015 – 2023, Historic And Forecast Growth Rate, Split By Region
  • Table 7: Global Biologics Market, 2019-2023, Growth And Market Share Comparison, By Region
  • Table 8: Global Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 9: Global Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 10: Global Monoclonal Antibodies (MAbS) Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 11: Global Monoclonal Antibodies (MAbS) Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 12: Global Therapeutic Proteins Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 13: Global Therapeutic Proteins Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 14: Global Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 15: Global Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 16: Global Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 17: Global Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 18: Global Biologics Market, Segmentation By Drug Classification, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 19: Global Biologics Market, Segmentation By Drug Classification, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 20: Global Biologics Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 21: Global Biologics Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 22: Global Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 23: Global Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 24: Global Biologics Market Value, Market Size As A Percentage Of Global GDP, 2015 – 2023
  • Table 25: Global Biologics Market, Per Capita Average Biologics Market Industry Expenditure, 2015 – 2023, ($)
  • Table 26: Asia-Pacific Biologics Market, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
  • Table 27: Asia Pacific Biologics Market, GDP Per Capita, By Country, 2015-2019, $
  • Table 28: Asia-Pacific Biologics Market, Pharmaceutical Drugs Market Size, By Country, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Billion
  • Table 29: Asia Pacific Biologics Market, Population By Age Group, By Country, 2015-2023, Thousands
  • Table 30: Asia-Pacific Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 31: Asia-Pacific Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 32: Asia-Pacific Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 33: Asia-Pacific Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 34: Asia-Pacific Biologics Market, 2019, By Country, Value ($ Million)
  • Table 35: Asia-Pacific Biologics Market, 2015 – 2023, Historic And Forecast Growth Rate, By Country
  • Table 36: Asia-Pacific Biologics Market, 2019 – 2023, Growth And Market Share Comparison, By Country
  • Table 37: Asia-Pacific Per Capita Biologics Expenditure, By Country, 2019, $
  • Table 38: Estimated Number of Enterprises And Average Revenue Per Enterprise, Biologics Market, 2019, Asia-Pacific Countries
  • Table 39: Estimated Number of Employees And Average Revenue Per Employee, Biologics Market, 2019, Asia-Pacific Countries
  • Table 40: Australia Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 41: Australia Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 42: Australia Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 43: Australia Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 44: China Biologics Market, Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 45: China Biologics Market, GDP Per Capita, By Country, 2015-2019, $
  • Table 46: China Biologics Market, Pharmaceutical Drugs Market Size, By Country, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Billion
  • Table 47: China Biologics Market, Population By Age Group, 2015-2023, Thousands
  • Table 48: China Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 49: China Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 50: China Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 51: China Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 52: Hong Kong Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 53: Hong Kong Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 54: India Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 55: India Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 56: India Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 57: India Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 58: Indonesia Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 59: Indonesia Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 60: Indonesia Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 61: Indonesia Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 62: Japan Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 63: Japan Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 64: Japan Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 65: Japan Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 66: Malaysia Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 67: Malaysia Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 68: New Zealand Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 69: New Zealand Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 70: Philippines Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 71: Philippines Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 72: Singapore Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 73: Singapore Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 74: South Korea Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 75: South Korea Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 76: South Korea Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 77: South Korea Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 78: Thailand Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 79: Thailand Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 80: Vietnam Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 81: Vietnam Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 82: Western Europe Biologics Market, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
  • Table 83: Western Europe Biologics Market, GDP Per Capita, By Country, 2015-2019, $
  • Table 84: Western Europe Biologics Market, Pharmaceutical Drugs Market Size, By Country, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Billion
  • Table 85: Western Europe Biologics Market, Population By Age Group, By Country, 2015-2023, Thousands
  • Table 86: Western Europe Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 87: Western Europe Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 88: Western Europe Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 89: Western Europe Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 90: Western Europe Biologics Market, 2019, By Country, Value ($ Million)
  • Table 91: Western Europe Biologics Market, 2015 – 2023, Historic And Forecast Growth Rate, By Country
  • Table 92: Western Europe Biologics Market, 2019 – 2023, Growth And Market Share Comparison, By Country
  • Table 93: Western Europe Per Capita Biologics Expenditure, By Country, 2019, $
  • Table 94: Estimated Number of Enterprises And Average Revenue Per Enterprise, Biologics Market, 2019, Western Europe Countries
  • Table 95: Estimated Number of Employees And Average Revenue Per Employee, Biologics Market, 2019, Western Europe Countries
  • Table 96: Austria Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 97: Austria Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 98: Belgium Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 99: Belgium Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 100: Denmark Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 101: Denmark Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 102: Finland Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 103: Finland Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 104: France Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 105: France Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 106: France Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 107: France Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 108: Germany Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 109: Germany Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 110: Germany Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 111: Germany Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 112: Ireland Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 113: Ireland Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 114: Italy Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 115: Italy Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 116: Italy Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 117: Italy Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 118: Netherlands Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 119: Netherlands Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 120: Norway Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 121: Norway Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 122: Portugal Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 123: Portugal Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 124: Spain Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 125: Spain Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 126: Spain Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 127: Spain Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 128: Sweden Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 129: Sweden Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 130: Switzerland Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 131: Switzerland Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 132: UK Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 133: UK Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 134: UK Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 135: UK Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 136: Eastern Europe Biologics Market, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
  • Table 137: Eastern Europe Biologics Market, GDP Per Capita, By Country, 2015-2019, $
  • Table 138: Eastern Europe Biologics Market, Pharmaceutical Drugs Market Size, By Country, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Billion
  • Table 139: Eastern Europe Biologics Market, Population By Age Group, By Country, 2015-2023, Thousands
  • Table 140: Eastern Europe Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 141: Eastern Europe Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 142: Eastern Europe Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 143: Eastern Europe Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 144: Eastern Europe Biologics Market, 2019, By Country, Value ($ Million)
  • Table 145: Eastern Europe Biologics Market, 2015 – 2023, Historic And Forecast Growth Rate, By Country
  • Table 146: Eastern Europe Biologics Market, 2019 – 2023, Growth And Market Share Comparison, By Country
  • Table 147: Eastern Europe Per Capita Biologics Expenditure, By Country, 2019, $
  • Table 148: Estimated Number of Enterprises And Average Revenue Per Enterprise, Biologics Market, 2019, Eastern Europe Countries
  • Table 149: Estimated Number of Employees And Average Revenue Per Employee, Biologics Market, 2019, Eastern Europe Countries
  • Table 150: Czech Republic Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 151: Czech Republic Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 152: Poland Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 153: Poland Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 154: Romania Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 155: Romania Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 156: Russia Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 157: Russia Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 158: Russia Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 159: Russia Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 160: North America Biologics Market, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
  • Table 161: North America Biologics Market, GDP Per Capita, By Country, 2015-2019, $
  • Table 162: North America Biologics Market, Pharmaceutical Drugs Market Size, By Country, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Billion
  • Table 163: North America Biologics Market, Population By Age Group, By Country, 2015-2023, Thousands
  • Table 164: North America Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 165: North America Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 166: North America Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 167: North America Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 168: North America Biologics Market, 2019, By Country, Value ($ Million)
  • Table 169: North America Biologics Market, 2015 – 2023, Historic And Forecast Growth Rate, By Country
  • Table 170: North America Biologics Market, 2019 – 2023, Growth And Market Share Comparison, By Country
  • Table 171: North America Per Capita Biologics Expenditure, By Country, 2019, $
  • Table 172: Estimated Number of Enterprises And Average Revenue Per Enterprise, Biologics Market, 2019, North America Countries
  • Table 173: Estimated Number of Employees And Average Revenue Per Employee, Biologics Market, 2019, North America Countries
  • Table 174: Canada Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 175: Canada Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 176: Mexico Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 177: Mexico Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 178: USA Biologics Market, Per Capita Healthcare Expenditure, 2015-2019, $
  • Table 179: USA Biologics Market, GDP Per Capita, 2015-2019, $
  • Table 180: USA Biologics Market, Pharmaceutical Drugs Market Size, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Billion
  • Table 181: USA Biologics Market, Population By Age Group, 2015-2023, Thousands
  • Table 182: USA Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 183: USA Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 184: USA Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 185: USA Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 186: South America Biologics Market, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
  • Table 187: South America Biologics Market, GDP Per Capita, By Country, 2015-2019, $
  • Table 188: South America Biologics Market, Pharmaceutical Drugs Market Size, By Country, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Billion
  • Table 189: South America Biologics Market, Population By Age Group, By Country, 2015-2023, Thousands
  • Table 190: South America Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 191: South America Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 192: South America Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 193: South America Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 194: South America Biologics Market, 2019, By Country, Value ($ Million)
  • Table 195: South America Biologics Market, 2015 – 2023, Historic And Forecast Growth Rate, By Country
  • Table 196: South America Biologics Market, 2019 – 2023, Growth And Market Share Comparison, By Country
  • Table 197: South America Per Capita Biologics Expenditure, By Country, 2019, $
  • Table 198: Estimated Number of Enterprises And Average Revenue Per Enterprise, Biologics Market, 2019, South America Countries
  • Table 199: Estimated Number of Employees And Average Revenue Per Employee, Biologics Market, 2019, South America Countries
  • Table 200: Argentina Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 201: Argentina Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 202: Brazil Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 203: Brazil Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 204: Brazil Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 205: Brazil Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 206: Chile Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 207: Chile Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 208: Colombia Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 209: Colombia Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 210: Peru Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 211: Peru Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 212: Venezuela Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 213: Venezuela Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 214: Middle East Biologics Market, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
  • Table 215: Middle East Biologics Market, GDP Per Capita, By Country, 2015-2019, $
  • Table 216: Middle East Biologics Market, Pharmaceutical Drugs Market Size, By Country, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Billion
  • Table 217: Middle East Biologics Market, Population By Age Group, By Country, 2015-2023, Thousands
  • Table 218: Middle East Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 219: Middle East Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 220: Middle East Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 221: Middle East Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 222: Middle East Biologics Market, 2019, By Country, Value ($ Million)
  • Table 223: Middle East Biologics Market, 2015 – 2023, Historic And Forecast Growth Rate, By Country
  • Table 224: Middle East Biologics Market, 2019 – 2023, Growth And Market Share Comparison, By Country
  • Table 225: Middle East Per Capita Biologics Expenditure, By Country, 2019, $
  • Table 226: Estimated Number of Enterprises And Average Revenue Per Enterprise, Biologics Market, 2019, Middle East Countries
  • Table 227: Estimated Number of Employees And Average Revenue Per Employee, Biologics Market, 2019, Middle East Countries
  • Table 228: Israel Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 229: Israel Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 230: Saudi Arabia Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 231: Saudi Arabia Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 232: Turkey Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 233: Turkey Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 234: UAE Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 235: UAE Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 236: Africa Biologics Market, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
  • Table 237: Africa Biologics Market, GDP Per Capita, By Country, 2015-2019, $
  • Table 238: Africa Biologics Market, Pharmaceutical Drugs Market Size, By Country, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Billion
  • Table 239: Africa Biologics Market, Population By Age Group, By Country, 2015-2023, Thousands
  • Table 240: Africa Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 241: Africa Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 242: Africa Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Table 243: Africa Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, $ Million
  • Table 244: Africa Biologics Market, 2019, By Country, Value ($ Million)
  • Table 245: Africa Biologics Market, 2015 – 2023, Historic And Forecast Growth Rate, By Country
  • Table 246: Africa Biologics Market, 2019 – 2023, Growth And Market Share Comparison, By Country
  • Table 247: Africa Per Capita Biologics Expenditure, By Country, 2019, $
  • Table 248: Estimated Number of Enterprises And Average Revenue Per Enterprise, Biologics Market, 2019, Africa Countries
  • Table 249: Estimated Number of Employees And Average Revenue Per Employee, Biologics Market, 2019, Africa Countries
  • Table 250: Egypt Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 251: Egypt Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 252: Nigeria Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 253: Nigeria Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 254: South Africa Biologics Market, Historic, 2015 – 2019, $ Million
  • Table 255: South Africa Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Table 256: Global Biologics Market, Key Competitor Estimated Market Shares, 2019, Percentage (%)
  • Table 257: Pfizer Inc. – Financial Performance, 2015 – 2019, $ Billion
  • Table 258: F. Hoffmann-La Roche AG – Financial Performance, 2015 – 2019, $ Billion
  • Table 2259: AbbVie Inc.– Financial Performance, 2015 - 2019, $ Billion
  • Table 260: Merck & Co., Inc. – Financial Performance, 2015-2019, $ Billion
  • Table 261: Johnson & Johnson – Financial Performance, 2015 – 2019, $ Billion
  • Table 262: Global  Pharmaceuticals Market, Segmentation By Type, 2015 – 2023, $ Billion
  • Table 263: Global Pharmaceuticals Market, 2019, Split By Region
  • Table 264: Global Pharmaceuticals Market, 2015 – 2023, Historic And Forecast Growth Rate, Split By Region
  • Table 265: Global Biologics Market Size Gain ($ Million), 2019 – 2023, By Country
  • Table 266: Global Biologics Market Size Gain ($ Million), Segmentation By Type, 2019 – 2023
  • Table 267: Global Biologics Market Size Gain ($ Million), Segmentation By Route Of Administration, 2019 – 2023
  • Table 268: Global Biologics Market Size Gain ($ Million), Segmentation By Drug Classification, 2019 – 2023
  • Table 269: Global Biologics Market Size Gain ($ Million), Segmentation By Mode Of Purchase, 2019 – 2023
  • Table 270: Global Biologics Market Size Gain ($ Million), Segmentation By Distribution Channel, 2019 – 2023
  • Table 271: Global Monoclonal Antibodies Market Size Gain ($ Million), Segmentation By Type, 2019 – 2023
  • Table 272: Global Therapeutic Proteins Market Size Gain ($ Million), Segmentation By Type, 2019 – 2023
  • Table 273: Global Vaccines Market Size Gain ($ Million), Segmentation By Type, 2019 – 2023
  • Table 274: Biologics - Market Data Sources

List Of Figures

    Figure 1: Global Biologics Market Segmentation By Type
  • Figure 2: Global Monoclonal Antibodies (MAbS) Market Segmentation By Type
  • Figure 3: Global Therapeutic Proteins Market Segmentation By Type
  • Figure 4: Global Vaccines Market Segmentation By Type
  • Figure 5: Global Biologics Market Segmentation By Route Of Administration
  • Figure 6: Global Biologics Market Segmentation By Drug Classification
  • Figure 7: Global Biologics Market Segmentation By Mode Of Purchase
  • Figure 8: Global Biologics Market Segmentation By Distribution Channel
  • Figure 9: Biologics Industry, Supply Chain Analysis
  • Figure 10: Global Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 11: Global Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 12: Global Biologics Market, By Region, Historic and Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 13: Global Biologics Market, 2015 – 2023, Historic And Forecast Growth Rate, Split By Region
  • Figure 14: Global Biologics Market, 2019-2023, Growth And Market Share Comparison, By Region
  • Figure 15: Global Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 16: Global Monoclonal Antibodies (MAbS) Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 17: Global Therapeutic Proteins Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 18: Global Vaccines Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 19: Global Biologics Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 20: Global Biologics Market, Segmentation By Drug Classification, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 21: Global Biologics Market, Segmentation By Mode Of Purchase, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 22: Global Biologics Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 23: Asia-Pacific Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 24: Asia-Pacific Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 25: Asia-Pacific Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 26: Asia-Pacific Biologics Market, 2019, By Country, Value ($ Million)
  • Figure 27: Asia-Pacific Biologics Market, 2015 – 2023, Historic And Forecast Growth Rate, By Country
  • Figure 28: Asia-Pacific Biologics Market, 2019 – 2023, Growth And Market Share Comparison, By Country
  • Figure 29: Australia Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 30: Australia Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 31: Australia Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 32: China Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 33: China Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 34: China Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 35: Hong Kong Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 36: Hong Kong Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 37: India Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 38: India Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 39: India Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 40: Indonesia Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 41: Indonesia Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 42: Indonesia Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 43: Japan Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 44: Japan Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 45: Japan Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 46: Malaysia Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 47: Malaysia Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 48: New Zealand Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 49: New Zealand Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 50: Philippines Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 51: Philippines Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 52: Singapore Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 53: Singapore Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 54: South Korea Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 55: South Korea Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 56: South Korea Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 57: Thailand Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 58: Thailand Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 59: Vietnam Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 60: Vietnam Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 61: Western Europe Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 62: Western Europe Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 63: Western Europe Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 64: Western Europe Biologics Market, 2019, By Country, Value ($ Million)
  • Figure 65: Western Europe Biologics Market, 2015 – 2023, Historic And Forecast Growth Rate, By Country
  • Figure 66: Western Europe Biologics Market, 2019 – 2023, Growth And Market Share Comparison, By Country
  • Figure 67: Austria Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 68: Austria Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 69: Belgium Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 70: Belgium Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 71: Denmark Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 72: Denmark Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 73: Finland Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 74: Finland Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 75: France Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 76: France Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 77: France Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 78: Germany Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 79: Germany Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 80: Germany Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 81: Ireland Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 82: Ireland Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 83: Italy Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 84: Italy Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 85: Italy Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 86: Netherlands Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 87: Netherlands Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 88: Norway Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 89: Norway Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 90: Portugal Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 91: Portugal Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 92: Spain Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 93: Spain Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 94: Spain Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 95: Sweden Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 96: Sweden Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 97: Switzerland Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 98: Switzerland Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 99: UK Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 100: UK Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 101: UK Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 102: Eastern Europe Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 103: Eastern Europe Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 104: Eastern Europe Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 105: Eastern Europe Biologics Market, 2019, By Country, Value ($ Million)
  • Figure 106: Eastern Europe Biologics Market, 2015 – 2023, Historic And Forecast Growth Rate, By Country
  • Figure 107: Eastern Europe Biologics Market, 2019 – 2023, Growth And Market Share Comparison, By Country
  • Figure 108: Czech Republic Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 109: Czech Republic Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 110: Poland Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 111: Poland Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 112: Romania Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 113: Romania Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 114: Russia Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 115: Russia Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 116: Russia Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 117: North America Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 118: North America Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 119: North America Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 120: North America Biologics Market, 2019, By Country, Value ($ Million)
  • Figure 121: North America Biologics Market, 2015 – 2023, Historic And Forecast Growth Rate, By Country
  • Figure 122: North America Biologics Market, 2019 – 2023, Growth And Market Share Comparison, By Country
  • Figure 123: Canada Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 124: Canada Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 125: Mexico Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 126: Mexico Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 127: USA Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 128: USA Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 129: USA Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 130: South America Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 131: South America Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 132: South America Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 133: South America Biologics Market, 2019, By Country, Value ($ Million)
  • Figure 134: South America Biologics Market, 2015 – 2023, Historic And Forecast Growth Rate, By Country
  • Figure 135: South America Biologics Market, 2019 – 2023, Growth And Market Share Comparison, By Country
  • Figure 136: Argentina Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 137: Argentina Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 138: Brazil Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 139: Brazil Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 140: Brazil Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 141: Chile Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 142: Chile Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 143: Colombia Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 144: Colombia Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 145: Peru Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 146: Peru Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 147: Venezuela Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 148: Venezuela Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 149: Middle East Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 150: Middle East Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 151: Middle East Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 152: Middle East Biologics Market, 2019, By Country, Value ($ Million)
  • Figure 153: Middle East Biologics Market, 2015 – 2023, Historic And Forecast Growth Rate, By Country
  • Figure 154: Middle East Biologics Market, 2019 – 2023, Growth And Market Share Comparison, By Country
  • Figure 155: Israel Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 156: Israel Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 157: Saudi Arabia Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 158: Saudi Arabia Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 159: Turkey Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 160: Turkey Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 161: UAE Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 162: UAE Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 163: Africa Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 164: Africa Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 165: Africa Biologics Market, Segmentation By Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, %
  • Figure 166: Africa Biologics Market, 2019, By Country, Value ($ Million)
  • Figure 167: Africa Biologics Market, 2015 – 2023, Historic And Forecast Growth Rate, By Country
  • Figure 168: Africa Biologics Market, 2019 – 2023, Growth And Market Share Comparison, By Country
  • Figure 169: Egypt Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 170: Egypt Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 171: Nigeria Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 172: Nigeria Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 173: South Africa Biologics Market, Historic, 2015 – 2019, $ Million
  • Figure 174: South Africa Biologics Market, Forecast, 2019 – 2023, 2025F, 2030F, $ Million
  • Figure 175: Global Biologics Market, Key Competitor Estimated Market Shares, 2019, Percentage (%)
  • Figure 176: Pfizer Inc. – Financial Performance, 2015 – 2019, $ Billion
  • Figure 177: F. Hoffmann-La Roche AG – Financial Performance, 2015 – 2019, $ Billion
  • Figure 178: Merck & Co., Inc. – Financial Performance, 2015-2019, $ Billion
  • Figure 179: Johnson & Johnson –  Financial Performance, 2015 – 2019,$ Billion
  • Figure 180: Global Pharmaceuticals Market, Segmentation By Type, 2015 – 2023, $ Billion
  • Figure 181: Global Pharmaceuticals Market, 2019, Split By Region
  • Figure 182: Global Pharmaceuticals Market, 2015 – 2023, Historic And Forecast Growth Rate, Split By Region
Global Anti-Infective Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Cell and Gene Therapy Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Pharmaceutical Drugs And Biologics Logistics Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Pharmaceutical Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Microbiome Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global G-CSF (Granulocyte Colony Stimulating Factors) Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Therapeutic Proteins Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
CRISPR Technology Market - By Product Type (Cas9 And gRNA, Design Tools, Plasmid And Vector), By End-User (Academic Research Organizations, Biopharmaceutical Companies, Agricultural Biotechnology Companies, Contract Research Organizations (CROs), By Application (Biomedical, Agriculture, Diagnostics), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report
Anti-Viral Drug Therapy Market - By Drug Class (DNA (Nucleotide) Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors), By Application (HIV, Hepatitis, Herpes, Influenza), Anti-Viral Drug Therapy Market Size, Opportunities And Strategies - Global Anti-Viral Drug Therapy Market Forecast To 2030
View Report
Anti-Viral Drug Therapy Market - By Drug Class (DNA (Nucleotide) Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors), By Application (HIV, Hepatitis, Herpes, Influenza), Anti-Viral Drug Therapy Market Size, Opportunities And Strategies - Global Anti-Viral Drug Therapy Market Forecast To 2030
View Report
Laboratory Information System Global Market Report 2021 - By Product (Standalone LIS, Integrated LIS), By End User (Hospital Laboratories, Independent Laboratories, Physician Office Laboratories), By Component (Software, Services), COVID-19 Growth And Change
View Report
3D Diagnostic Imaging Services Global Market Report 2021 - By Technique (Ultrasound, MRI, X-ray, Computed Tomography), By Application (Oncology, Cardiology, Orthopedic), By End User (Diagnostic Centers, Hospitals, Research Centers), COVID-19 Growth And Change
View Report
Healthcare Reimbursement Global Market Report 2021 - By Claims (Underpaid, Full Paid), By Payers (Private Payers, Public Payers), By Service Provider (Physician Office, Hospitals, Diagnostic Laboratories), COVID-19 Growth And Change
View Report
Metabolomics Global Market Report 2021 - By Product & Service (Metabolomics Instruments, Metabolomics Bioinformatics Tools & Services), By Application (Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics, Personalized Medicine), By Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors Of Metabolism), By Metabolomics Instruments (Separation Techniques, Detection Techniques), By Metabolomics Bioinformatics Tools & Services (Bioinformatics Tools And Databases, Bioinformatics Services), COVID-19 Growth And Change
View Report
Synthetic Biology Global Market Report 2021 - By Technology (Nucleotide Synthesis And Sequencing, Bioinformatics, Microfluidics, Genetic Engineering), By Application (Pharmaceuticals And Diagnostics, Chemicals, Biofuels, Bioplastics), By Product Type (Oligonucleotides, Enzymes, Cloning And Assembly Kits, Xeno-Nucleic Acids (XNA), Chassis Organism), COVID-19 Growth And Change
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)